Literature DB >> 19892887

Animal models of arrhythmogenic cardiomyopathy.

Mark D McCauley1, Xander H T Wehrens.   

Abstract

Arrhythmogenic cardiomyopathies are a heterogeneous group of pathological conditions that give rise to myocardial dysfunction with an increased risk for atrial or ventricular arrhythmias. Inherited defects in cardiomyocyte proteins in the sarcomeric contractile apparatus, the cytoskeleton and desmosomal cell-cell contact junctions are becoming recognized increasingly as major causes of sudden cardiac death in the general population. Animal models have been developed for the systematic dissection of the genetic pathways involved in the pathogenesis of arrhythmogenic cardiomyopathies. This review presents an overview of current animal models for arrhythmogenic right ventricular cardiomyopathy (ARVC), hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) associated with cardiac arrhythmias and sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892887      PMCID: PMC2776113          DOI: 10.1242/dmm.002840

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  58 in total

1.  Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.

Authors:  Calum A MacRae; Walter Birchmeier; Ludwig Thierfelder
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

2.  Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Eduardo Garcia-Gras; Raffaella Lombardi; Michael J Giocondo; James T Willerson; Michael D Schneider; Dirar S Khoury; Ali J Marian
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

Authors:  B C Knollmann; J D Potter
Journal:  Trends Cardiovasc Med       Date:  2001-07       Impact factor: 6.677

5.  Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.

Authors:  Björn C Knollmann; Paulus Kirchhof; Syevda G Sirenko; Hubertus Degen; Anne E Greene; Tilmann Schober; Jessica C Mackow; Larissa Fabritz; James D Potter; Martin Morad
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

6.  Molecular mechanisms of inherited arrhythmias.

Authors:  Cordula M Wolf; Charles I Berul
Journal:  Curr Genomics       Date:  2008-05       Impact factor: 2.236

7.  Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  Crystal M Ripplinger; Wenwen Li; Jennifer Hadley; Junjie Chen; Florence Rothenberg; Raffaella Lombardi; Samuel A Wickline; Ali J Marian; Igor R Efimov
Journal:  Circ Res       Date:  2007-09-20       Impact factor: 17.367

8.  Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy.

Authors:  Alice E Zemljic-Harpf; Joel C Miller; Scott A Henderson; Adam T Wright; Ana Maria Manso; Laila Elsherif; Nancy D Dalton; Andrea K Thor; Guy A Perkins; Andrew D McCulloch; Robert S Ross
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Authors:  Ray E Hershberger; Joann Lindenfeld; Luisa Mestroni; Christine E Seidman; Matthew R G Taylor; Jeffrey A Towbin
Journal:  J Card Fail       Date:  2009-03       Impact factor: 5.712

Review 10.  Sarcomeric proteins and inherited cardiomyopathies.

Authors:  Sachio Morimoto
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

View more
  19 in total

1.  Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.

Authors:  Deqiang Li; Ying Liu; Mitsunori Maruyama; Wuqiang Zhu; Hanying Chen; Wenjun Zhang; Sean Reuter; Shien-Fong Lin; Laura S Haneline; Loren J Field; Peng-Sheng Chen; Weinian Shou
Journal:  Hum Mol Genet       Date:  2011-08-31       Impact factor: 6.150

2.  Connecting enterovirus infection to dystrophin dysfunction in dilated cardiomyopathy.

Authors:  Qiongling Wang; Xander H T Wehrens
Journal:  Ann Transl Med       Date:  2016-10

Review 3.  Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities.

Authors:  Jeanne M Nerbonne
Journal:  Curr Opin Pharmacol       Date:  2014-03-13       Impact factor: 5.547

4.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 5.  Targeting ryanodine receptors for anti-arrhythmic therapy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 6.  Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility.

Authors:  Adriana Blazeski; Renjun Zhu; David W Hunter; Seth H Weinberg; Elias T Zambidis; Leslie Tung
Journal:  Prog Biophys Mol Biol       Date:  2012-08-07       Impact factor: 3.667

Review 7.  Calcium Signaling and Cardiac Arrhythmias.

Authors:  Andrew P Landstrom; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2017-06-09       Impact factor: 17.367

8.  Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.

Authors:  Adriana Blazeski; Justin Lowenthal; Yin Wang; Roald Teuben; Renjun Zhu; Sharon Gerecht; Gordon Tomaselli; Leslie Tung
Journal:  Tissue Eng Part A       Date:  2019-02-15       Impact factor: 3.845

9.  Inflammatory dilated cardiomyopathy in Abcg5-deficient mice.

Authors:  Dennis W Wilson; Karen L Oslund; Bonnie Lyons; Oded Foreman; Lisa Burzenski; Karen L Svenson; Thomas H Chase; Leonard D Shultz
Journal:  Toxicol Pathol       Date:  2012-11-05       Impact factor: 1.902

Review 10.  Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.

Authors:  Adriana Blazeski; Renjun Zhu; David W Hunter; Seth H Weinberg; Kenneth R Boheler; Elias T Zambidis; Leslie Tung
Journal:  Prog Biophys Mol Biol       Date:  2012-08-07       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.